NASDAQ · Analyst Forecast

GeneDx Holdings Corp. (WGS) Stock Forecast & Price Target

$47.29 NASDAQ: WGS Market Cap $1.42B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 11, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering GeneDx Holdings Corp. (WGS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For GeneDx Holdings Corp., analysts forecast revenue rising from $426.85M in 2025 to $984.55M in 2030; the average estimate for 2030 earnings per share is $4.88; with published estimates ranging from $4.65 to $5.07; 6 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$47.29
Consensus targetThe average of the price targets analysts have published.$80.25
Median targetThe middle target, less affected by a single outlier.$84.00
Highest targetThe most optimistic published target.$90.00
Lowest targetThe most pessimistic published target.$63.00
Difference from priceHow far the consensus target sits from today’s price.+69.7%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$411.26M$426.85M$439.40M5
2026$459.85M$477.28M$491.32M6
2027$555.55M$576.61M$593.57M5
2028$663.73M$722.75M$771.54M5
2029$794.20M$824.30M$848.55M2
2030$948.59M$984.55M$1.01B2

Earnings per share forecast

YearLowAverageHighAnalysts
2025$1.29$1.36$1.415
2026$0.31$0.33$0.346
2027$1.18$1.24$1.295
2028$1.87$1.96$2.045
2029$3.15$3.31$3.432
2030$4.65$4.88$5.072

GeneDx Holdings Corp. (WGS) forecast — frequently asked questions

What is the analyst price target for GeneDx Holdings Corp.?

Analysts covering GeneDx Holdings Corp. (WGS) have a consensus price target of $80.25, 69.7% above the current price of $47.29. Published targets range from $63.00 to $90.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for GeneDx Holdings Corp.'s earnings?

The average analyst estimate for GeneDx Holdings Corp. (WGS) earnings per share in 2030 is 4.88, with individual estimates between 4.65 and 5.07.

How much revenue is GeneDx Holdings Corp. expected to make?

Analysts forecast GeneDx Holdings Corp. (WGS) revenue of $984.55M in 2030, based on 2 published estimates.

How many analysts cover WGS?

6 analysts contribute estimates for GeneDx Holdings Corp. (WGS). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Diagnostics & Research stocks

TMO forecastDHR forecastIDXX forecastA forecastWAT forecastIQV forecastNTRA forecastMTD forecastILMN forecastLH forecastAll Medical - Diagnostics & Research stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.